These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17553686)

  • 21. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
    Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
    Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
    Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
    Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear localisation of the endocannabinoid metabolizing enzyme fatty acid amide hydrolase (FAAH) in invasive trophoblasts and an association with recurrent miscarriage.
    Chamley LW; Bhalla A; Stone PR; Liddell H; O'Carroll S; Kearn C; Glass M
    Placenta; 2008 Nov; 29(11):970-5. PubMed ID: 18805581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome.
    Núñez E; Benito C; Tolón RM; Hillard CJ; Griffin WS; Romero J
    Neuroscience; 2008 Jan; 151(1):104-10. PubMed ID: 18068305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.
    Camilleri M; Carlson P; McKinzie S; Grudell A; Busciglio I; Burton D; Baxter K; Ryks M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G13-9. PubMed ID: 17962356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid amide hydrolase in brain ventricular epithelium: mutually exclusive patterns of expression in mouse and rat.
    Egertová M; Michael GJ; Cravatt BF; Elphick MR
    J Chem Neuroanat; 2004 Nov; 28(3):171-81. PubMed ID: 15482903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas.
    Rubio M; de Miguel R; Fernández-Ruiz J; Gutiérrez-López D; Carai MA; Ramos JA
    Drug Alcohol Depend; 2009 Jan; 99(1-3):354-8. PubMed ID: 18922654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A human fatty acid amide hydrolase (FAAH) functional gene variant is associated with lower blood pressure in young males.
    Sarzani R; Bordicchia M; Salvi F; Cola G; Franchi E; Battistoni I; Mancinelli L; Giovagnoli A; Dessì-Fulgheri P; Rappelli A
    Am J Hypertens; 2008 Aug; 21(8):960-3. PubMed ID: 18497731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.
    Kage KL; Richardson PL; Traphagen L; Severin J; Pereda-Lopez A; Lubben T; Davis-Taber R; Vos MH; Bartley D; Walter K; Harlan J; Solomon L; Warrior U; Holzman TF; Faltynek C; Surowy CS; Scott VE
    J Neurosci Methods; 2007 Mar; 161(1):47-54. PubMed ID: 17083980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
    Conforti P; Ramos C; Apostol BL; Simmons DA; Nguyen HP; Riess O; Thompson LM; Zuccato C; Cattaneo E
    Mol Cell Neurosci; 2008 Sep; 39(1):1-7. PubMed ID: 18571429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional and cellular gene expression changes in human Huntington's disease brain.
    Hodges A; Strand AD; Aragaki AK; Kuhn A; Sengstag T; Hughes G; Elliston LA; Hartog C; Goldstein DR; Thu D; Hollingsworth ZR; Collin F; Synek B; Holmans PA; Young AB; Wexler NS; Delorenzi M; Kooperberg C; Augood SJ; Faull RL; Olson JM; Jones L; Luthi-Carter R
    Hum Mol Genet; 2006 Mar; 15(6):965-77. PubMed ID: 16467349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone reverts LPS-reduced FAAH activity in murine peripheral blood mononuclear cells by a receptor-mediated fashion.
    Wolfson ML; Aisemberg J; Salazar AI; Domínguez Rubio AP; Vercelli CA; Franchi AM
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):97-105. PubMed ID: 23906535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
    Wong HK; Bauer PO; Kurosawa M; Goswami A; Washizu C; Machida Y; Tosaki A; Yamada M; Knöpfel T; Nakamura T; Nukina N
    Hum Mol Genet; 2008 Oct; 17(20):3223-35. PubMed ID: 18658163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD; Richardson D; Robinson I; Garle MJ; Patel A; Sun Y; Sagar DR; Bennett AJ; Alexander SP; Kendall DA; Barrett DA; Chapman V
    Neuropharmacology; 2008 Jul; 55(1):85-93. PubMed ID: 18534634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
    Labar G; Vliet FV; Wouters J; Lambert DM
    Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
    Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
    Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population.
    Iwasaki S; Ishiguro H; Higuchi S; Onaivi ES; Arinami T
    Psychiatr Genet; 2007 Aug; 17(4):215-20. PubMed ID: 17621164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.
    Chiang KP; Gerber AL; Sipe JC; Cravatt BF
    Hum Mol Genet; 2004 Sep; 13(18):2113-9. PubMed ID: 15254019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
    Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
    J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.